Modified bi‐weekly cetuximab‐cisplatin and 5‐FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients

BACKGROUND: The standard chemotherapy treatment protocol for patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) requires as long as 56 days of hospitalization over six months. Where the 5‐Fluorouracil (5‐FU) pump is available, most treatment will be on outpatient bases,...

Descripción completa

Detalles Bibliográficos
Autores principales: Meirovitz, Amichay, Bergerson, Shani, Hirshoren, Nir, Weinberger, Jeffrey M., Bersudski, Evgeniya, Daniel, Sharon, Sheva, Kim, Perez, Cesar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955066/
https://www.ncbi.nlm.nih.gov/pubmed/34184405
http://dx.doi.org/10.1002/cnr2.1479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955066/
https://www.ncbi.nlm.nih.gov/pubmed/34184405
http://dx.doi.org/10.1002/cnr2.1479

Ejemplares similares